NTRK1 and neoplasm: Overexpression and activation of receptor tyrosine kinases (RTKs), genetic alterations in the phosphatidylinositol 3-kinase (PI3K) pathway components, a hypoxic tumor microenvironment, and chronic inflammation collectively contribute to Akt-mTOR pathway hyperactivation.